Cardiac Monitoring & Cardiac Rhythm Management Devices Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Others) By Cardiac Rhythm Management Devices (Defibrillator v/s Pacemakers) By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others) By Region & Competition, 2021-2031F

January 2026 | 181 pages | ID: CF50456C5622EN
TechSci Research

Abstracts

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is projected to expand from USD 26.38 Billion in 2025 to USD 37.53 Billion by 2031, reflecting a compound annual growth rate of 6.05%. These technologies encompass medical devices designed to regulate heart activity or detect arrhythmias through electrical therapy or continuous tracking. The primary factors fueling this market trajectory are the growing prevalence of chronic cardiovascular diseases and an aging population necessitating constant physiological monitoring. As reported by the European Society of Cardiology in 2024, cardiovascular disease remained the leading cause of death across member nations, accounting for over 3 million annual fatalities. This substantial health burden highlights the critical need for therapeutic and diagnostic solutions capable of preventing adverse cardiac incidents.

However, market expansion is significantly hindered by high product development costs and stringent reimbursement frameworks within various healthcare systems. These regulatory and financial obstacles frequently postpone the commercial introduction of novel technologies and limit patient access to sophisticated treatment options, particularly in cost-sensitive areas. Consequently, these hurdles create a complex environment where the speed of innovation is often tempered by economic and compliance-related constraints.

Market Driver

The escalating global prevalence of cardiovascular diseases and arrhythmias acts as the fundamental driver propelling the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market. As the burden of chronic heart conditions grows worldwide, there is an urgent necessity for early arrhythmia detection and continuous physiological tracking to lower mortality risks. This rising demand correlates strongly with the spread of lifestyle-associated risk factors, such as obesity, which severely exacerbate cardiovascular vulnerability. According to the World Heart Federation's 'World Heart Report 2025' published in May 2025, high body mass index is now responsible for nearly one in ten cardiovascular disease deaths globally, emphasizing the need for effective management. Additionally, the American Heart Association's '2025 Heart Disease and Stroke Statistics' from January 2025 noted that cardiovascular disease caused roughly 19.41 million deaths worldwide in 2021, highlighting the vast patient population requiring intervention.

Concurrently, a transition toward leadless and minimally invasive cardiac rhythm management solutions is transforming the market by providing safer, more patient-centric alternatives to conventional transvenous systems. Innovations like pulsed field ablation and leadless pacemakers are rapidly increasing in popularity because they minimize procedural complications and accelerate recovery times. This shift is fueling significant commercial growth as healthcare providers increasingly adopt these advanced, less invasive techniques. For instance, Boston Scientific reported in its 'Fourth Quarter and Full Year 2024 Results' in February 2025 that it achieved a 22.4 percent rise in fourth-quarter net sales, a surge driven largely by the swift adoption of its cutting-edge rhythm management and interventional cardiology portfolios.

Market Challenge

The extensive costs associated with product development and stringent reimbursement frameworks constitute a major obstacle to the expansion of the global market for cardiac monitoring and rhythm management devices. Creating complex Class III devices, such as continuous monitors and implantable cardioverter-defibrillators, necessitates substantial capital investment to satisfy clinical trial requirements and regulatory standards. When these demands are coupled with inflexible reimbursement policies that frequently limit or delay coverage for emerging technologies, manufacturers encounter significant financial strain. This economic pressure disincentivizes investment in innovation, compelling companies to allocate resources toward compliance rather than research and development, which ultimately decelerates the commercialization of vital cardiac solutions.

These regulatory and financial barriers directly constrain the availability of advanced treatments in critical regions. Manufacturers are increasingly delaying product introductions in markets characterized by complex compliance mandates to avoid incurring excessive costs. According to data from MedTech Europe in 2024, the percentage of major medical device manufacturers choosing the European Union as their primary launch geography fell by 33% because of the resource intensity and unpredictability of the regulatory landscape. Such deferrals in market entry hinder the growth of the global sector and restrict patient access to essential cardiac rhythm management therapies.

Market Trends

The integration of artificial intelligence for predictive analytics and real-time ECG analysis is fundamentally transforming diagnostic workflows by improving the accuracy and speed of arrhythmia detection. This technological advancement goes beyond basic data storage, employing deep learning algorithms to recognize subtle physiological patterns that conventional monitoring might miss, thus enabling earlier medical intervention. Regulatory authorities are increasingly validating these software-driven solutions, signaling broad sector confidence in algorithmic decision-making. As highlighted by Cardiovascular Business in the January 2025 article 'FDA has now cleared more than 1,000 AI models,' ten new cardiology-specific AI algorithms received approval within a recent two-month period, establishing the specialty as the second-largest field for algorithmic innovation.

Simultaneously, the move toward home-based monitoring solutions and remote cardiac telemetry is decentralizing care delivery, facilitating continuous patient oversight beyond clinical environments. This trend is propelled by the necessity to enhance patient compliance and decrease hospital readmissions through the use of unobtrusive, wearable patch technologies that transmit data directly to medical providers. The commercial success of these ambulatory platforms underscores the increasing dependence on extended, out-of-clinic diagnostic services. For example, iRhythm Technologies reported in its 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025 that fourth-quarter revenue rose by 24.0% to $164.3 million, a growth primarily driven by the surging demand for its Zio ambulatory monitoring services.

Key Market Players

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson
• Biotronik SE & Co. KG
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• GE Healthcare
• MicroPort Scientific Corporation
• LivaNova PLC

Report Scope

In this report, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices
• ECG Devices
• Implantable Loop Recorders
• Mobile Cardiac Telemetry Devices
• Cardiac Output Monitoring Devices
• Others
• Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Rhythm Management Devices
• Defibrillator v/s Pacemakers
• Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User
• Hospitals & Clinics
• Cardiac Care Centers
• Ambulatory Surgery Centers
• Others
• Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market.

Available Customizations:

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Others)
  5.2.2. By Cardiac Rhythm Management Devices (Defibrillator v/s Pacemakers)
  5.2.3. By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Cardiac Monitoring Devices
  6.2.2. By Cardiac Rhythm Management Devices
  6.2.3. By End User
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Cardiac Monitoring Devices
      6.3.1.2.2. By Cardiac Rhythm Management Devices
      6.3.1.2.3. By End User
  6.3.2. Canada Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Cardiac Monitoring Devices
      6.3.2.2.2. By Cardiac Rhythm Management Devices
      6.3.2.2.3. By End User
  6.3.3. Mexico Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Cardiac Monitoring Devices
      6.3.3.2.2. By Cardiac Rhythm Management Devices
      6.3.3.2.3. By End User

7. EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Cardiac Monitoring Devices
  7.2.2. By Cardiac Rhythm Management Devices
  7.2.3. By End User
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Cardiac Monitoring Devices
      7.3.1.2.2. By Cardiac Rhythm Management Devices
      7.3.1.2.3. By End User
  7.3.2. France Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Cardiac Monitoring Devices
      7.3.2.2.2. By Cardiac Rhythm Management Devices
      7.3.2.2.3. By End User
  7.3.3. United Kingdom Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Cardiac Monitoring Devices
      7.3.3.2.2. By Cardiac Rhythm Management Devices
      7.3.3.2.3. By End User
  7.3.4. Italy Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Cardiac Monitoring Devices
      7.3.4.2.2. By Cardiac Rhythm Management Devices
      7.3.4.2.3. By End User
  7.3.5. Spain Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Cardiac Monitoring Devices
      7.3.5.2.2. By Cardiac Rhythm Management Devices
      7.3.5.2.3. By End User

8. ASIA PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Cardiac Monitoring Devices
  8.2.2. By Cardiac Rhythm Management Devices
  8.2.3. By End User
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Cardiac Monitoring Devices
      8.3.1.2.2. By Cardiac Rhythm Management Devices
      8.3.1.2.3. By End User
  8.3.2. India Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Cardiac Monitoring Devices
      8.3.2.2.2. By Cardiac Rhythm Management Devices
      8.3.2.2.3. By End User
  8.3.3. Japan Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Cardiac Monitoring Devices
      8.3.3.2.2. By Cardiac Rhythm Management Devices
      8.3.3.2.3. By End User
  8.3.4. South Korea Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Cardiac Monitoring Devices
      8.3.4.2.2. By Cardiac Rhythm Management Devices
      8.3.4.2.3. By End User
  8.3.5. Australia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Cardiac Monitoring Devices
      8.3.5.2.2. By Cardiac Rhythm Management Devices
      8.3.5.2.3. By End User

9. MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Cardiac Monitoring Devices
  9.2.2. By Cardiac Rhythm Management Devices
  9.2.3. By End User
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Cardiac Monitoring Devices
      9.3.1.2.2. By Cardiac Rhythm Management Devices
      9.3.1.2.3. By End User
  9.3.2. UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Cardiac Monitoring Devices
      9.3.2.2.2. By Cardiac Rhythm Management Devices
      9.3.2.2.3. By End User
  9.3.3. South Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Cardiac Monitoring Devices
      9.3.3.2.2. By Cardiac Rhythm Management Devices
      9.3.3.2.3. By End User

10. SOUTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Cardiac Monitoring Devices
  10.2.2. By Cardiac Rhythm Management Devices
  10.2.3. By End User
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Cardiac Monitoring Devices
      10.3.1.2.2. By Cardiac Rhythm Management Devices
      10.3.1.2.3. By End User
  10.3.2. Colombia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Cardiac Monitoring Devices
      10.3.2.2.2. By Cardiac Rhythm Management Devices
      10.3.2.2.3. By End User
  10.3.3. Argentina Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Cardiac Monitoring Devices
      10.3.3.2.2. By Cardiac Rhythm Management Devices
      10.3.3.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Medtronic plc
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Abbott Laboratories
15.3. Boston Scientific Corporation
15.4. Johnson & Johnson
15.5. Biotronik SE & Co. KG
15.6. Koninklijke Philips N.V.
15.7. Siemens Healthineers AG
15.8. GE Healthcare
15.9. MicroPort Scientific Corporation
15.10. LivaNova PLC

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER